Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Response to cisplatin upon depletion of SNRNP200

ABSTRACT: Response to cisplatin upon depletion of SNRNP200

PROVIDER: PRJNA817247 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18360600.fastq.gz	Fastqsanger.gz
	SRR18360601.fastq.gz	Fastqsanger.gz
	SRR18360602.fastq.gz	Fastqsanger.gz
	SRR18360603.fastq.gz	Fastqsanger.gz
	SRR18360604.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Response to cisplatin upon depletion of SNRNP200

Project description:The goal is to define the impact of depleting SNRNP200 on the transcriptional response to the DNA damaging agent cisplatin

2022-03-24 | GSE198887 | GEO

Targeted depletion of renal ALKBH7 by bismuth drug prevents cisplatin-induced acute kidney injury

Project description:Cisplatin is a potent chemotherapeutic drug widely used to treat cancers. Unfortunately, its overaccumulation in kidney proximal tubular cell (PTC) shuts down fatty acid oxidation, resulting in cell necrosis and acute kidney injury (AKI). Bismuth drugs have long been used to treat gastrointestinal tract disorder and Helicobacter pylori infection. Interestingly, bismuth drugs also mitigate cisplatin-induced AKI, but the underlying mechanism remains unknown. In this study, we found 50nM bismuth specifically reduces cisplatin-induced cell necrosis. Using multiomics and protein-small molecule interaction techniques, we identified mitochondrial protein ALKBH7 as a specific target of bismuth. And ALKBH7 is depleted upon bismuth treatment. Bismuth treatment and ALKBH7 knockdown shared a proteomic similarity in suppressing programmed necrosis and promoting fatty acid metabolism. By gene knockout and silencing, we showed ALKBH7 depletion indeed greatly mitigates cisplatin-induced cell necrosis. We further demonstrated bismuth specifically depletes renal ALKBH7, prevents cisplatin-induced AKI and greatly increases survival rate in mice. Overall, we conclude ALKBH7 is specific target of bismuth drugs, and ALKBH7 depletion suppresses cisplatin-induced PTC necrosis and prevents AKI by preserving fatty acid metabolism.

2024-07-30 | PXD054362 |

Gene expression analysis upon mtDNA depletion

Project description:Gene expression analysis upon mtDNA depletion

| PRJNA390778 | ENA

Changes in gene expression upon treatment of SH-SY5Y cells to cisplatin

Project description:In this study we investigated the changes in mRNA expression upon treatment of SH-SY5Y cells to 10µM cisplatin for 72h.

2017-06-12 | GSE86842 | GEO

PolyA-sequencing in Jurkat cells upon CDK12 depletion.

Project description:PolyA-sequencing in Jurkat cells upon CDK12 depletion.

| PRJNA679028 | ENA

Transcriptome alteration upon ZNF281 depletion in HCC cells

Project description:Transcriptome alteration upon ZNF281 depletion in HCC cells

| PRJNA610754 | ENA

Effect of SRMS deficiency on gene expression upon cisplatin treatment in human ovarian cancer cells

Project description:This study was designed to evaluate the transcriptomic alterations upon SRMS deficiency after cisplatin exposure in a human ovarian cancer cell line.

2023-06-07 | GSE206226 | GEO

Effect of cisplatin in depletion MAGEA6 expression of esophageal cancer cells

Project description:Effect of cisplatin in depletion MAGEA6 expression of esophageal cancer cells

| PRJNA956915 | ENA

Dynamic response of annexin A11-associated gene expression to cisplatin treatment

Project description:Based on a time-course study of cisplatin response in ovarian cancer cells with/without suppression of annexin A11 expression using whole genome oligonucleotide microarrays, we identified a set of differentially expressed genes associated with annexin A11 expression and patterns of gene expressions in response to cisplatin exposure. Keywords: human ovarian cancer cell lines 2008 cells (one ovarian cancer cell line) were transfected with ANXA11_RNAi or control_RNAi for 2 days and then treated with 10 ÂµM cisplatin (Sigma) for 0, 8, 16, 24 hours. Total RNA of 8 samples were prepared for gene expression profiling using the Agilent 44K whole genome oligonucleotide microarrays.

2010-04-08 | E-GEOD-13893 | biostudies-arrayexpress

Differentially expressed genes upon TbSAC3 depletion

Project description:This study examines differential expression upon TbSAC3 depletion in Trypanosoma brucei brucei strain 29.13

2023-02-22 | GSE79773 | GEO